Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia

Umberto Basile*, Mariapaola Marino, Laura Gragnani, Cecilia Napodano*, Francesca Gulli, Krizia Pocino, Serena Lorini, Stefano Angelo Santini, Valerio Basile, Luca Miele, Anna Linda Zignego, Gian Ludovico Rapaccini

*Corresponding author

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Infections, autoimmunity and cancer play a role as determinants of etiology in Hepatitis C virus (HCV) related mixed cryoglobulinemia (MC). Several factors of risk have been suggested as markers of pathogenesis and progression of HCV-related MC into B cell Non-Hodgkin's Lymphoma (B-NHL). Here, we evaluated IgG subclass distribution, free light chains (FLCs) and vascular endothelial growth factor (VEGF) as a new combination of biomarkers. Methods: We measured IgG1–4 subclasses, FLCs and VEGF levels in sera 53 from HCV-related MC, in comparison with 40 sera from HCV negative patients with rheumatoid arthritis (RA) and 30 from healthy blood donors (HBD). Results: IgG3 levels were significantly higher in HCV-MC patients with a decrement of IgG2 and IgG4; FLC levels significantly increased in both MC and RA patients' groups; serological VEGF was higher in HCV-MC patients than in HBD in correlation with k and λ levels. Conclusion: Our results suggest that a specific IgG subclasses pattern together with raised levels of FLCs and VEGF could represent the biomarker “signature” of an inflammation multistage of acquired immune system.
Original languageEnglish
Pages (from-to)112687-112693
Number of pages7
JournalJournal of Immunological Methods
Volume476
DOIs
Publication statusPublished - 2020

Keywords

  • Biomarkers
  • Free light chains
  • Hepatitis C virus
  • Mixed cryoglobulinemia
  • Vascular endothelial growth factor

Fingerprint

Dive into the research topics of 'Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia'. Together they form a unique fingerprint.

Cite this